GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, ALK, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PPARA, PTGES, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
12.691 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, ALK, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD3, EGFR, F10, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
10.9776 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, ALK, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD3, EGFR, F10, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
10.9776 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, ESR1, FDPS, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
10.8666 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HSPA1A, IGF1R, INSR, KDR, PPARA, PTGES, SMAD3, SRC, TEK, TYR |
10.731 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, EGFR, ESR1, FABP3, FABP4, FDPS, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, PPARA, PTGES |
10.731 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALK, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, PTGES, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
10.731 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CYP19A1, CYP1A1, CYP1B1, DRD3, EGFR, ESR1, F10, F3, FABP3, FABP4, FLT3, GPR35, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MET, PPARA, PTK2, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
9.94396 |
[BP] GO:0042127 |
regulation of cell proliferation
|
AKR1B1, ALK, APP, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, DRD3, EGFR, ESR1, ESRRA, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP12, NUAK1, PIM1, PTGES, PTK2, SMAD3, SRC, TEK, XDH |
9.52638 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, ALK, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, DRD3, EGFR, F10, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
9.45738 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AXL, BCL2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, IGF1R, INSR, PPARA, PTGES, SRC, TEK, TYR |
9.32442 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FDPS, FUT7, GBA2, HSPA1A, PIM1, PPARA, PTGES, TYR, XDH |
9.09942 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
8.57809 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, ALK, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, F10, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PTK2, PTPN1, SRC, TEK, XDH |
8.55623 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, PTGES, SRC, TYR |
8.5337 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ESR1, ESRRA, FLT3, HSD11B2, PTGES, SRC, TEK, TYR |
8.50923 |
[BP] GO:0046777 |
protein autophosphorylation
|
ALK, AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, PTK2, SRC, TEK |
8.50923 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, ALK, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
8.50155 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HSPA1A, IGF1R, INSR, KDR, PPARA, PTGES, SMAD3, SRC, TEK, TYR |
8.492 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, INSR, KDR, PPARA, PTK2, SMAD3, SRC, TEK, TYR |
8.40034 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, ALK, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
8.39247 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, ALK, ALOX15, APP, AXL, BCL2, CYP1B1, EGFR, F10, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MET, PTK2, PTPN1, SRC, TEK, XDH |
8.25171 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A6, TYR |
8.23805 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, ALK, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PIM1, PPARA, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
8.19853 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALK, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, FDPS, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTK2, PTPN1, SRC, TEK, TNKS, XDH |
7.9956 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, ALK, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, DRD3, EGFR, ESRRA, F10, F3, FABP4, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
7.73823 |
[BP] GO:0006468 |
protein phosphorylation
|
ALK, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTK2, SRC, TEK, TNKS |
7.73823 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA6, CA7, CA9 |
7.69024 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, ALK, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PPARA, PTGES, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
7.67198 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
ALK, AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, PTK2, SRC, TEK |
7.64589 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALK, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, FDPS, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTK2, PTPN1, SRC, TEK, TNKS, XDH |
7.60719 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
ALK, AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, PTK2, SRC, TEK |
7.5931 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, ALK, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PPARA, PTGES, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
7.58884 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, INSR, PPARA, SRC, TEK |
7.4663 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, IGF1R, INSR, PPARA, SMAD3, SRC, TEK |
7.4486 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD3, EGFR, F10, F3, INSR, MET, PTK2, SRC, TEK, XDH |
7.12038 |
[BP] GO:0048583 |
regulation of response to stimulus
|
AKR1B1, ALK, ALOX15, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, F10, F3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PPARA, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
7.04522 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, AKR1B1, ALK, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PIM1, PPARA, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.9923 |
[BP] GO:0009966 |
regulation of signal transduction
|
AKR1B1, ALK, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.98097 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, PTGES, SRC |
6.64719 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALK, ALOX15, ALPL, APP, AXL, BCL2, CA2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, INSR, KDR, PIM1, PPARA, PTK2, SMAD3, SRC, TEK, TYR |
6.52756 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.48224 |
[BP] GO:0016310 |
phosphorylation
|
ALK, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTK2, SRC, TEK, TNKS |
6.32496 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALK, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD17B2, INSR, KDR, MET, PIM1, PPARA, PTK2, SMAD3, SRC, TEK, TNKS2, TYR |
6.27071 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, AKR1B1, ALK, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA2, CA6, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ESR1, ESRRA, F10, F3, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP12, NUAK1, PPARA, PTGES, PTK2, PTPN1, SMAD3, SRC, TEK, TYR |
6.0035 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, F10, F3, INSR, MET, PTK2, SRC, TEK |
6.0035 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, ALK, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HSPA1A, IGF1R, KDR, MET, PIM1, PPARA, PTK2, PTPN1, SMAD3, SRC, TEK, XDH |
5.9921 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, EGFR, FABP3, FABP4, FDPS, FUT7, GBA2, MET, PPARA, PTGES |
5.96321 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, PTK2, SMAD3, SRC, TEK |
5.94033 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, ALK, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HSPA1A, IGF1R, KDR, MET, PIM1, PTK2, PTPN1, SMAD3, SRC, TEK, XDH |
5.86166 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, AKR1B10, ALK, ALOX15, ALOX5, ALPL, APP, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESRRB, F10, F3, FABP4, HSD11B2, HSD17B2, IGF1R, INSR, MET, MMP12, PIM1, PPARA, SMAD3, SRC, TEK, TNKS2, TYR |
5.80684 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, PTK2, SMAD3, SRC, TEK |
5.78233 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, DRD3, EGFR, ESR1, F3, FLT3, IGF1R, INSR, KDR, MMP12, PIM1, PTK2, TEK |
5.71258 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALK, ALPL, AOX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, DRD3, DUSP3, EGFR, ESR1, F10, F3, FLT3, FUT7, GBA2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PPARA, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
5.70573 |
[BP] GO:0040012 |
regulation of locomotion
|
APP, BCL2, CDK6, CYP19A1, CYP1B1, DRD3, EGFR, F10, F3, IGF1R, INSR, KDR, MET, PTK2, SMAD3, SRC, TEK |
5.68174 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, PTK2, SMAD3, SRC, TEK |
5.6627 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ALK, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PPARA, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.6385 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ALK, ALOX15, APP, BCL2, CDC25B, DRD3, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, NUAK1, PPARA, PTK2, PTPN1, SMAD3, SRC, TEK, XDH |
5.59544 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ALK, ALOX15, APP, BCL2, CDC25B, DRD3, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, NUAK1, PPARA, PTK2, PTPN1, SMAD3, SRC, TEK, XDH |
5.53526 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, PTK2, SMAD3, SRC, TEK |
5.50944 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, PTK2, SRC |
5.42462 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ALOX15, APP, AXL, BCL2, CA2, CA7, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD3, EGFR, F10, F3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PPARA, PTK2, PTPN1, SMAD3, SRC, TEK |
5.41388 |
[BP] GO:2000145 |
regulation of cell motility
|
APP, BCL2, CDK6, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, PTK2, SMAD3, SRC, TEK |
5.3704 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD3, FDPS, GBA2, TYR |
5.3453 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, PIM1, PPARA, PTK2, PTPN1, SMAD3, SRC, TEK |
5.32661 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ALK, ALOX15, APP, AURKB, BCL2, CDC25B, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PPARA, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.31611 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, ALK, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HSPA1A, IGF1R, KDR, PIM1, PTK2, PTPN1, SMAD3, SRC, TEK, XDH |
5.29868 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ALK, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PPARA, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.27311 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ALK, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PPARA, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.18001 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A6, PTGES |
5.11944 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, PIM1, PTK2, PTPN1, SMAD3, SRC, TEK |
5.10282 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
ALK, AURKB, AXL, BCL2, CSNK2A1, EGFR, F10, FLT3, IGF1R, INSR, KDR, MET, PTK2, SRC, TEK, TNKS |
5.04559 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, PTGES |
4.98735 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APP, AURKB, BCL2, CDC25B, CDK6, CYP1A1, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TNKS |
4.96135 |
[BP] GO:0030334 |
regulation of cell migration
|
APP, BCL2, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, PTK2, SMAD3, SRC, TEK |
4.96135 |
[BP] GO:0051270 |
regulation of cellular component movement
|
APP, BCL2, CDK6, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, PTK2, SMAD3, SRC, TEK |
4.9557 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
4.94682 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.83341 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, CDK6, KDR, PTK2, SMAD3, SRC, TEK |
4.83341 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, PTGES |
4.8087 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, SMAD3, SRC |
4.74595 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.70391 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CDK6, CYP1A1, CYP1B1, EGFR, ESR1, FABP4, FLT3, IGF1R, INSR, KDR, SMAD3, SRC |
4.63641 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, AKR1B1, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, HSPA1A, IGF1R, KDR, MET, MMP12, PIM1, PPARA, PTGES, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
4.60632 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
ALK, AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, PTK2, PTPN1, SRC, TEK |
4.58087 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ALK, ALOX15, APP, BCL2, CDC25B, EGFR, ESRRB, FABP3, FLT3, INSR, KDR, PTK2, PTPN1, SMAD3, SRC, TEK, XDH |
4.5256 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ALK, ALOX15, APP, BCL2, CDC25B, EGFR, ESRRB, FABP3, FLT3, INSR, KDR, PTK2, PTPN1, SMAD3, SRC, TEK, XDH |
4.5256 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.49764 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, BCL2, DRD3, HSPA1A, INSR, KDR, MET, SMAD3, SRC, TEK, TNKS, TNKS2 |
4.49327 |
[BP] GO:0065009 |
regulation of molecular function
|
ALK, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, MET, NUAK1, PIM1, PPARA, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
4.46265 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, PIM1, PTK2, PTPN1, SMAD3, SRC, TEK |
4.45743 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, DRD3, FABP3, PPARA |
4.44807 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, FDPS, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.29989 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
ALOX15, BCL2, CDK6, KDR, PTK2, SMAD3, SRC, TEK |
4.28767 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, ALK, AURKB, BCL2, CYP1A1, EGFR, ESR1, FLT3, MET, PIM1, SRC, TEK, TYR |
4.21884 |
[BP] GO:0080134 |
regulation of response to stress
|
APP, CDK6, CYP19A1, DUSP3, EGFR, ESR1, F3, FABP4, HSPA1A, IGF1R, MET, MMP12, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
4.21189 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ALK, APP, AURKB, BCL2, CDC25B, CSNK2A1, DRD3, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, NUAK1, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
4.20817 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AURKB, AXL, BCL2, DRD3, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK, TNKS, TNKS2 |
4.19623 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, PTK2, SRC, TEK |
4.17445 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, FDPS, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PTGES |
4.16703 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ALOX15, BCL2, CDK6, CYP19A1, DRD3, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP12, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
4.12121 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, HSPA1A, IGF1R, KDR, MET, MMP12, PIM1, PPARA, PTGES, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
4.11101 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
ALK, AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, PTK2, PTPN1, SMAD3, SRC, TEK |
4.09905 |
[BP] GO:0006464 |
cellular protein modification process
|
ALK, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
4.0717 |
[BP] GO:0036211 |
protein modification process
|
ALK, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
4.0717 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ALK, ALOX15, APP, BCL2, CDC25B, DUSP3, EGFR, ESRRB, FABP4, FLT3, IGF1R, INSR, KDR, PPARA, PTK2, PTPN1, SRC, TEK, XDH |
4.06175 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, DRD3, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, INSR, MET, SMAD3, SRC |
4.02507 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, BCL2, CA12, CA2, CA7, DRD3, EGFR, ESR1, FABP3, FABP4, GPR35, INSR, MET, SMAD3 |
3.97862 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, BCL2, CA2, CA7, CDK6, DRD3, EGFR, KDR, SRC, TNKS, TNKS2 |
3.97114 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A6 |
3.9198 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, PPARA, PTGES |
3.89653 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, BCL2, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, PTK2, SRC |
3.84871 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ALK, ALOX15, APP, DUSP3, EGFR, FLT3, IGF1R, INSR, KDR, PTPN1, SRC, TEK, XDH |
3.83911 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, NUAK1, PTPN1, SMAD3, SRC |
3.79243 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ALK, APP, AURKB, BCL2, CDC25B, EGFR, ESR1, F3, FLT3, HSPA1A, INSR, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
3.78739 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, PTGES |
3.78739 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ALK, APP, AURKB, BCL2, CDC25B, EGFR, ESR1, ESR2, F3, FLT3, HSPA1A, INSR, MET, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, XDH |
3.78513 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ALK, ALOX15, APP, BCL2, CDC25B, EGFR, ESRRB, FLT3, INSR, KDR, PTK2, PTPN1, SRC, TEK, XDH |
3.77162 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, PTK2, SMAD3, SRC, TEK |
3.76038 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, PTK2, SMAD3, SRC, TEK |
3.76038 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.75179 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, BCL2, CA9, CDK6, CYP1A1, CYP1B1, DRD3, EGFR, FABP3, HSD11B2, KDR, SRC |
3.75179 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A6, PTGES |
3.73978 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.73771 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.72751 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ALK, ALOX15, APP, EGFR, FLT3, INSR, KDR, PTPN1, SRC, TEK, XDH |
3.72674 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD3, EGFR, HSD11B2, HSPA1A, PPARA, SMAD3, SRC, TEK, TYR |
3.72127 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, EGFR, FABP4, PTGES |
3.68299 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, PTK2, SMAD3, SRC, TEK |
3.66829 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ALK, ALOX15, APP, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, F3, FLT3, HSPA1A, INSR, KDR, PTK2, PTPN1, SMAD3, SRC, TEK, XDH |
3.66829 |
[BP] GO:0051338 |
regulation of transferase activity
|
ALK, APP, AURKB, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, PTK2, PTPN1, SRC, TEK, TNKS |
3.66809 |
[BP] GO:0051726 |
regulation of cell cycle
|
APP, AURKB, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, SRC, TNKS |
3.6262 |
[BP] GO:0044092 |
negative regulation of molecular function
|
APP, AURKB, CSNK2A1, CYP1B1, DRD3, DUSP3, ESR1, FABP4, GPR35, IGF1R, MET, PIM1, PPARA, PTPN1, SRC, TNKS |
3.6262 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DRD3, EGFR, FABP3, FLT3, HSD11B2, IGF1R, INSR, PPARA, SRC, TEK, TYR |
3.62387 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DRD3, EGFR, HSPA1A |
3.61316 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR, FDPS |
3.60532 |
[BP] GO:0040008 |
regulation of growth
|
APP, BCL2, CSNK2A1, DRD3, EGFR, ESR2, HSPA1A, INSR, PIM1, PTK2, SMAD3, TNKS2 |
3.54284 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, SRC |
3.50935 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, DRD3, FABP3, PPARA |
3.50084 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ALOX15, BCL2, CYP1A1, EGFR, PPARA, SMAD3 |
3.4492 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX15, BCL2, CDK6, CYP1B1, DUSP3, KDR, NUAK1, PPARA, PTK2, SMAD3, SRC, TEK |
3.44707 |
[BP] GO:0043412 |
macromolecule modification
|
ALK, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.42186 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ALK, ALOX15, APP, BCL2, CDC25B, EGFR, ESR1, F3, FLT3, HSPA1A, INSR, KDR, PTK2, PTPN1, SMAD3, SRC, TEK, XDH |
3.41705 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, HSD11B2, IGF1R, INSR, PPARA, SRC, TEK |
3.41705 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ALK, ALOX15, APP, BCL2, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, PTK2, PTPN1, SRC, TEK, XDH |
3.39549 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, PTK2, SRC, TEK |
3.39497 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALK, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, ESR1, F10, F3, FLT3, FUT7, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PPARA, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.38002 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ALK, ALOX15, APP, BCL2, CDC25B, EGFR, FLT3, INSR, KDR, PTK2, PTPN1, SRC, TEK, XDH |
3.36387 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AURKB, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, IGF1R, INSR, MET, MMP12, PPARA, PTPN1, SMAD3, SRC, TNKS, TNKS2 |
3.3475 |
[BP] GO:0050793 |
regulation of developmental process
|
APP, AXL, BCL2, CA2, CDK6, CYP1B1, DRD3, EGFR, ESR1, ESRRA, ESRRB, F3, INSR, KDR, NUAK1, PIM1, PPARA, PTK2, SMAD3, SRC, TEK, TNKS2, XDH |
3.32851 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DRD3, EGFR, FABP3, FLT3, HSD11B2, IGF1R, INSR, PPARA, SRC, TEK, TYR |
3.32264 |
[BP] GO:0048608 |
reproductive structure development
|
AXL, BCL2, CYP19A1, ESR1, HSD17B2, INSR, PTK2, SRC |
3.32219 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ALK, ALOX15, APP, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PPARA, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.32219 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PTK2, SRC, TEK |
3.31791 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
CYP1A1, DRD3, FABP3, FDPS, FLT3, PPARA, PTK2, SRC, TEK |
3.31531 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DUSP3, EGFR, KDR, PTPN1, SRC, TEK |
3.28622 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.28622 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR, FDPS |
3.28622 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
APP, AXL, BCL2, CA2, CDK6, CYP1B1, DRD3, EGFR, ESR1, ESRRA, ESRRB, F3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, PIM1, PTK2, SMAD3, SRC, TEK, TNKS2, XDH |
3.26931 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, PTK2, SRC, TEK |
3.26931 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.26931 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, PTK2, SRC, TEK |
3.26898 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APP, AURKB, CDC25B, CYP1A1, DRD3, DUSP3, EGFR, INSR, SRC |
3.26034 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, GBA2, PPARA, PTGES |
3.22988 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
3.21806 |
[BP] GO:0031399 |
regulation of protein modification process
|
ALK, ALOX15, APP, BCL2, CDC25B, DUSP3, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, NUAK1, PTK2, PTPN1, SRC, TEK, XDH |
3.21545 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
3.21545 |
[BP] GO:0044267 |
cellular protein metabolic process
|
ALK, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.21497 |
[BP] GO:0010564 |
regulation of cell cycle process
|
APP, AURKB, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, DRD3, EGFR, HSPA1A, INSR, TNKS |
3.21475 |
[BP] GO:0043549 |
regulation of kinase activity
|
ALK, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, PTK2, PTPN1, SRC, TEK |
3.21475 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, BCL2, DRD3, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MMP12, PTPN1, SMAD3, SRC, XDH |
3.21475 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD3, EGFR, ESR1, PPARA, SRC |
3.21396 |
[BP] GO:0007165 |
signal transduction
|
AKR1B1, ALK, APP, AXL, BCL2, CA1, CA2, CDK6, CSNK2A1, CYP1B1, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, PTGES, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.20933 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, BCL2, DRD3, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MMP12, PTPN1, SMAD3, SRC, XDH |
3.2036 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, DRD3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, INSR, KDR, MET, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.18106 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ALK, APP, AXL, BCL2, CA1, CSNK2A1, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.11674 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AURKB, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, KDR, MET, MMP12, PPARA, SMAD3, SRC, TNKS, TNKS2 |
3.10762 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, EGFR, IGF1R, INSR, SRC, TNKS, TNKS2 |
3.06788 |
[BP] GO:1901888 |
regulation of cell junction assembly
|
KDR, PTK2, SMAD3, SRC, TEK |
3.03883 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AURKB, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, IGF1R, INSR, KDR, MET, MMP12, PPARA, SMAD3, SRC, TNKS, TNKS2 |
3.03182 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, DRD3, KDR, SRC |
3.03003 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APP, CDC25B, CYP1A1, DRD3, DUSP3, INSR |
2.99971 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, EGFR, FLT3, HSD11B2, SRC |
2.99878 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD3, DUSP3, ESR1, HSPA1A, IGF1R, MET, PTPN1, SRC, XDH |
2.99151 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.9867 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.96663 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, EGFR, ESR1, ESRRB, HSD11B2, HSD17B2, INSR, PTK2, SRC |
2.95982 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD3, EGFR, TNKS, TNKS2 |
2.92842 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AXL, BCL2, CA2, CYP1B1, DRD3, EGFR, ESRRB, F3, HSPA1A, KDR, MET, MMP12, PIM1, SMAD3, SRC, TEK |
2.90752 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.90114 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
CYP19A1, DRD3, EGFR, ESR1, F3, FABP4, KDR, MET, MMP12, PPARA, SMAD3, TEK |
2.89747 |
[BP] GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity
|
FLT3, PTK2, SRC, TEK |
2.88641 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ALK, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, PTK2, PTPN1, SRC |
2.86804 |
[BP] GO:0051704 |
multi-organism process
|
APP, AXL, BCL2, CDK6, CYP1A1, DRD3, EGFR, FDPS, HSD11B2, HSPA1A, INSR, KDR, MET, MMP12, SMAD3, SRC |
2.85964 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, EGFR, FLT3, HSD11B2, SRC |
2.85664 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
APP, AXL, BCL2, CA2, CDK6, CYP1B1, DRD3, EGFR, ESR1, ESRRA, F3, INSR, KDR, PIM1, PTK2, SMAD3, SRC, TEK, XDH |
2.85424 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ALK, ALOX15, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PPARA, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.84676 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ALK, ALOX15, APP, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A2, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PPARA, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.83296 |
[BP] GO:0050801 |
ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, DRD3, EGFR, ESR1, FABP3, GPR35, SMAD3 |
2.82913 |
[BP] GO:0001954 |
positive regulation of cell-matrix adhesion
|
CDK6, KDR, SMAD3, TEK |
2.82913 |
[BP] GO:0050678 |
None
|
CDK6, EGFR, F3, KDR, MMP12, SMAD3, TEK, XDH |
2.821 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ALK, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, NUAK1, PTK2, PTPN1, SMAD3, SRC, TEK, XDH |
2.77352 |
[BP] GO:0048732 |
gland development
|
BCL2, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
2.77281 |
[BP] GO:2000811 |
negative regulation of anoikis
|
BCL2, PTK2, SRC |
2.75072 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.75072 |
[BP] GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling
|
EGFR, FLT3, KDR, PTK2, TEK |
2.75072 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ALK, AURKB, CDC25B, EGFR, FLT3, INSR, PTK2, PTPN1, SRC, TEK, TNKS |
2.74828 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ALK, DUSP3, EGFR, FLT3, IGF1R, INSR, PTPN1, SRC |
2.74275 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, BCL2, CYP1B1, EGFR, HSPA1A, SRC |
2.71867 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, PPARA, SMAD3, SRC, TNKS |
2.71867 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.70678 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AURKB, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, MET, MMP12, PPARA, SMAD3, SRC, TNKS, TNKS2 |
2.70431 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.68725 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, EGFR, INSR, SMAD3, XDH |
2.68725 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.68725 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.68725 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.68725 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.68725 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.66967 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, SRC |
2.66444 |
[BP] GO:0048729 |
tissue morphogenesis
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.63247 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, EGFR, SRC |
2.62661 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.62512 |
[BP] GO:0001666 |
response to hypoxia
|
BCL2, CYP1A1, HSD11B2, PPARA, SMAD3, SRC, TEK |
2.62512 |
[BP] GO:0010676 |
None
|
ESRRB, INSR, PPARA, SRC |
2.62512 |
[BP] GO:0043550 |
regulation of lipid kinase activity
|
FLT3, PTK2, SRC, TEK |
2.62512 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ACHE, AKR1B1, AKR1B10, ALK, ALPL, AOX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FLT3, FUT7, GBA2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PPARA, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
2.60647 |
[BP] GO:0010811 |
positive regulation of cell-substrate adhesion
|
ALOX15, CDK6, KDR, SMAD3, TEK |
2.60426 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.59664 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.582 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.582 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, GBA2, PIM1, PPARA, PTGES, TYR |
2.582 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.5755 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, SRC |
2.5755 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, GBA2, HSPA1A, MMP12, SRC, XDH |
2.57071 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.57071 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
BCL2, CYP1A1, HSD11B2, PPARA, SMAD3, SRC, TEK |
2.55996 |
[BP] GO:0016042 |
lipid catabolic process
|
AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
2.53059 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ALOX15, APP, AXL, BCL2, CA2, CA7, CYP19A1, DRD3, EGFR, GPR35, HSPA1A, INSR, MMP12, PPARA, PTPN1, SMAD3, SRC |
2.50251 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
BCL2, DRD3, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP12, PTPN1, SMAD3, SRC, XDH |
2.47993 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, EGFR, TEK |
2.47434 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALK, ALPL, APP, AXL, BCL2, CDC25B, CDK6, CYP1A1, EGFR, ESR1, ESRRB, FABP4, FLT3, FUT7, GBA2, KDR, MET, PTK2, SMAD3, SRC, TEK |
2.46342 |
[BP] GO:0035556 |
intracellular signal transduction
|
AKR1B1, ALK, AXL, BCL2, CYP1B1, DRD3, EGFR, IGF1R, INSR, KDR, MET, NUAK1, PTK2, PTPN1, SRC, TEK |
2.4364 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TNKS, TNKS2 |
2.4364 |
[BP] GO:0002682 |
regulation of immune system process
|
ALOX15, APP, AXL, BCL2, CA2, CDK6, CYP19A1, DUSP3, ESR1, ESRRA, HSPA1A, MMP12, PTK2, PTPN1, SMAD3, SRC |
2.43527 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CDK6, CYP1B1, EGFR, KDR, SRC |
2.42383 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ALK, ALOX15, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PPARA, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.41452 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.41452 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, SRC |
2.40597 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ALK, ALOX15, APP, BCL2, CDC25B, EGFR, FLT3, INSR, KDR, PTK2, PTPN1, SRC, TEK, XDH |
2.40223 |
[BP] GO:0033043 |
regulation of organelle organization
|
ALOX15, AURKB, BCL2, DRD3, HSPA1A, INSR, KDR, MET, PTK2, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.40223 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.39797 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ALK, ALOX15, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PPARA, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.37609 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, EGFR, KDR, SRC, TEK |
2.3758 |
[BP] GO:0009894 |
regulation of catabolic process
|
BCL2, CSNK2A1, EGFR, ESRRB, HSPA1A, INSR, KDR, MET, PPARA, PTK2, PTPN1, SMAD3 |
2.35517 |
[BP] GO:0070482 |
response to oxygen levels
|
BCL2, CYP1A1, HSD11B2, PPARA, SMAD3, SRC, TEK |
2.35433 |
[BP] GO:2000209 |
regulation of anoikis
|
BCL2, PTK2, SRC |
2.34778 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.34778 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, DRD3, EGFR, ESR1, GPR35, SMAD3 |
2.33448 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.33448 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.33448 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.33448 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.32988 |
[BP] GO:0032989 |
cellular component morphogenesis
|
APP, AXL, BCL2, EGFR, MET, PTK2, SRC, TEK |
2.32988 |
[BP] GO:0009605 |
response to external stimulus
|
ALK, ALPL, AXL, BCL2, CDK6, CYP1A1, CYP1A2, DRD3, EGFR, HSD11B2, MMP12, PTGES, SMAD3, SRC, TYR |
2.32401 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, CDK6, DUSP3, EGFR, HSPA1A, IGF1R, MET, NUAK1, PTPN1, XDH |
2.30913 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.30913 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.30913 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, PPARA, SRC |
2.3064 |
[BP] GO:0031347 |
regulation of defense response
|
CYP19A1, EGFR, ESR1, FABP4, HSPA1A, MMP12, PPARA, PTPN1, SMAD3, SRC, TEK |
2.30266 |
[BP] GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling
|
FLT3, KDR, PTK2, TEK |
2.28861 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, DRD3, KDR, SRC |
2.2754 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
APP, BCL2, DRD3, TNKS2 |
2.26553 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.26229 |
[BP] GO:0045913 |
None
|
ESRRB, INSR, PPARA, SRC |
2.24409 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ALK, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, NUAK1, PTK2, PTPN1, SMAD3, SRC, TEK, XDH |
2.24301 |
[BP] GO:0045596 |
None
|
APP, BCL2, CDK6, DRD3, EGFR, ESRRB, PPARA, PTK2, SMAD3, XDH |
2.24133 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, GBA2, PIM1, PPARA, PTGES, TYR |
2.24036 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
APP, AURKB, BCL2, CSNK2A1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, KDR, MET, MMP12, PPARA, PTPN1, SMAD3, SRC, TNKS, TNKS2, XDH |
2.23217 |
[BP] GO:0009987 |
cellular process
|
ACHE, AKR1B1, AKR1B10, ALK, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, GPR35, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PPARA, PTGES, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
2.22563 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.22371 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.22371 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.22371 |
[BP] GO:0048638 |
regulation of developmental growth
|
APP, BCL2, DRD3, INSR, PIM1, PTK2, TNKS2 |
2.21719 |
[BP] GO:0035239 |
tube morphogenesis
|
BCL2, EGFR, ESR1, MET, SMAD3, SRC |
2.21608 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
APP, DUSP3, EGFR, IGF1R, PTPN1, XDH |
2.21608 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
APP, DUSP3, EGFR, IGF1R, PTPN1, XDH |
2.20622 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, APP, AXL, BCL2, CA2, CYP19A1, DRD3, EGFR, INSR, MMP12, SMAD3, SRC |
2.18936 |
[BP] GO:0031099 |
regeneration
|
AXL, BCL2, CSNK2A1, EGFR, FLT3 |
2.18445 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, GBA2, PIM1, PPARA, PTGES, TYR |
2.18445 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.18445 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ALK, CDC25B, EGFR, FLT3, INSR, PTK2, PTPN1, SRC, TEK |
2.18443 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, KDR, PTK2, SRC |
2.17256 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.16635 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.16635 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.16635 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.16635 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CYP1A1, EGFR, HSD11B2, SRC, TYR |
2.15723 |
[BP] GO:0032868 |
None
|
FABP3, HSD11B2, INSR, PPARA, SRC |
2.15723 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCL2, EGFR, FLT3, HSD11B2 |
2.15723 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, PTGES, SRC |
2.14941 |
[BP] GO:0051254 |
None
|
APP, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, INSR, MET, MMP12, PPARA, SMAD3, SRC, TNKS |
2.10303 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.09736 |
[BP] GO:0009896 |
positive regulation of catabolic process
|
CSNK2A1, ESRRB, HSPA1A, INSR, KDR, PPARA, PTK2, PTPN1 |
2.07758 |
[BP] GO:0042060 |
None
|
ALOX15, EGFR, PPARA, SMAD3 |
2.07758 |
[BP] GO:0009653 |
anatomical structure morphogenesis
|
APP, AXL, BCL2, CA2, CA9, CYP1B1, EGFR, ESR1, INSR, MET, PTK2, SMAD3, SRC, TEK |
2.07701 |
[BP] GO:0035265 |
organ growth
|
BCL2, CYP19A1, ESR1 |
2.07286 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.07286 |
[BP] GO:0032204 |
None
|
AURKB, SRC, TNKS, TNKS2 |
2.06367 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD3, TYR |
2.06367 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4 |
2.04633 |
[BP] GO:0040007 |
None
|
APP, BCL2, CYP19A1, ESR1, SMAD3, SRC, TNKS2 |
2.04449 |
[BP] GO:1901890 |
None
|
KDR, SMAD3, TEK |
2.03856 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.0235 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.0235 |
[BP] GO:1990535 |
None
|
APP, INSR |
2.0235 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX15, ALOX5 |
2.0235 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.54629 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, EGFR, F10, FLT3, GBA2, HSD11B1, HSD11B2, HSD17B2, PTGES, PTPN1 |
3.19277 |
[CC] GO:0016020 |
membrane
|
ACHE, ALK, ALOX15, ALOX5, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DRD3, EGFR, ESR1, F10, F3, FLT3, FUT7, GBA2, GPR35, HSD11B1, HSD11B2, HSD17B2, IGF1R, INSR, KDR, MET, PIM1, PTGES, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR |
2.90752 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APP, AURKB, BCL2, CA1, CA2, CA4, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DRD3, DUSP3, EGFR, ESR1, ESR2, F10, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, PIM1, PTGES, PTK2, PTPN1, SMAD3, SRC, TNKS, TNKS2, TYR, XDH |
2.75072 |
[CC] GO:0044425 |
membrane part
|
ACHE, ALK, ALOX15, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DRD3, DUSP3, EGFR, ESR1, F10, F3, FLT3, FUT7, GBA2, GPR35, HSD11B1, HSD11B2, HSD17B2, IGF1R, INSR, KDR, MET, PTGES, PTK2, PTPN1, SRC, TEK, TYR |
2.67134 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.50552 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, EGFR, GBA2, HSD11B1, HSD11B2, HSD17B2, PTGES |
2.34239 |
[CC] GO:0048471 |
perinuclear region of cytoplasm
|
ACHE, AKR1B1, APP, CA4, EGFR, HSPA1A, PTGES, SRC, TNKS2, TYR |
2.3236 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ALK, ALOX15, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, DRD3, EGFR, ESR1, F10, F3, FLT3, GBA2, GPR35, IGF1R, INSR, KDR, MET, PIM1, PTK2, PTPN1, SMAD3, SRC, TEK |
2.22371 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, AKR1B1, AKR1B10, ALK, ALPL, AOX1, APP, AURKB, AXL, BCL2, CA1, CA2, CA4, CA6, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, HSPA1A, IGF1R, INSR, KDR, MMP12, NUAK1, PIM1, PPARA, PTK2, PTPN1, SMAD3, SRC, TNKS, TNKS2, TYR, XDH |
2.16928 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.0235 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALK, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FDPS, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PPARA, PTGES, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TYR, XDH |
13.5025 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, MMP12, PIM1, PPARA, PTPN1, SMAD3, TNKS, TYR, XDH |
13.5025 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, AKR1B10, ALK, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DUSP3, EGFR, F10, F3, FDPS, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PTGES, PTK2, PTPN1, SRC, TEK, TNKS, TNKS2, TYR, XDH |
13.5025 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
12.4275 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
ALK, AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
9.0293 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
ALK, AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
8.25171 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
7.9956 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
ALK, AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, PTK2, SRC, TEK |
7.73823 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
7.04361 |
[MF] GO:0004672 |
protein kinase activity
|
ALK, AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTK2, SRC, TEK |
6.61221 |
[MF] GO:0008144 |
drug binding
|
ACHE, ALK, AURKB, AXL, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, PTK2, SRC, TEK |
6.27625 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DRD3, ESR1, ESR2, ESRRA, ESRRB, F10, FDPS, MMP12, NUAK1, PIM1, PPARA, PTPN1, SMAD3, TNKS, TNKS2, TYR, XDH |
6.00864 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
5.99618 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, XDH |
5.84986 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
ALK, AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTK2, SRC, TEK |
5.62627 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP12, PPARA, PTPN1, SMAD3, TNKS |
5.44295 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
5.23787 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, F10, FDPS, MMP12, NUAK1, PIM1, PPARA, PTPN1, SMAD3, TNKS, TNKS2, TYR, XDH |
5.19666 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6 |
5.17816 |
[MF] GO:0016301 |
kinase activity
|
ALK, AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTK2, SRC, TEK |
5.177 |
[MF] GO:0043168 |
anion binding
|
ALK, ALOX15, AOX1, APP, AURKB, AXL, CDK6, CSNK2A1, EGFR, F10, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTGES, PTK2, SRC, TEK, XDH |
4.58379 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
4.34782 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
ALK, AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTK2, SRC, TEK |
4.30003 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AXL, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA |
4.08794 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1 |
4.05995 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.93172 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.93172 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, HSD11B2, HSD17B1, PTGES, SRC, XDH |
3.91265 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, TYR |
3.83872 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.78254 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.61071 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.54798 |
[MF] GO:0019899 |
enzyme binding
|
APP, AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, CYP2A6, DUSP3, EGFR, ESR1, ESR2, ESRRB, F3, HSPA1A, MET, PPARA, PTK2, PTPN1, SMAD3, SRC, TEK, TNKS2 |
3.52392 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.43904 |
[MF] GO:0038023 |
signaling receptor activity
|
ALK, AXL, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, PPARA, TEK |
3.41624 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.40108 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.38002 |
[MF] GO:0004871 |
signal transducer activity
|
ALK, AXL, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, PPARA, PTK2, SMAD3, TEK |
3.37773 |
[MF] GO:0036094 |
small molecule binding
|
ALK, AOX1, AURKB, AXL, CDK6, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTK2, SRC, TEK, XDH |
3.36045 |
[MF] GO:0000166 |
nucleotide binding
|
ALK, AOX1, AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTK2, SRC, TEK, XDH |
3.27442 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ALK, AOX1, AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTK2, SRC, TEK, XDH |
3.27332 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, SRC |
3.24389 |
[MF] GO:0060089 |
molecular transducer activity
|
ALK, AXL, CDK6, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, PPARA, TEK |
3.21545 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, PIM1, PPARA, PTPN1, SMAD3, SRC |
3.21475 |
[MF] GO:0005524 |
ATP binding
|
ALK, AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTK2, SRC, TEK |
3.10333 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, SRC |
3.09415 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
ALK, AURKB, AXL, CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, F10, F3, FLT3, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PTK2, PTPN1, SRC, TEK |
3.09142 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
ALK, AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTK2, SRC, TEK |
2.98798 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR |
2.97733 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.96663 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.96663 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
ALK, AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTK2, SRC, TEK |
2.96135 |
[MF] GO:0004872 |
receptor activity
|
ALK, AXL, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, PPARA, TEK |
2.85721 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, TYR |
2.85664 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.85664 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, PPARA, PTPN1, SMAD3, SRC |
2.85664 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.82913 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, MET, PPARA, PTPN1, SMAD3 |
2.74481 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ALK, AOX1, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FDPS, FLT3, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PPARA, PTK2, PTPN1, SMAD3, SRC, TEK, XDH |
2.63501 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.5755 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ALK, AOX1, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, EGFR, ESR1, ESR2, ESRRA, ESRRB, FDPS, FLT3, HSD11B2, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PIM1, PPARA, PTK2, PTPN1, SMAD3, SRC, TEK, XDH |
2.41452 |
[MF] GO:0005057 |
signal transducer activity, downstream of receptor
|
ALK, EGFR, INSR, KDR, SMAD3 |
2.35517 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.33448 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.33448 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.25607 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ALK, AOX1, APP, BCL2, CSNK2A1, EGFR, ESR1, ESR2, FLT3, IGF1R, KDR, MET, SMAD3, TYR, XDH |
2.18445 |
[MF] GO:0035639 |
purine ribonucleoside triphosphate binding
|
ALK, AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTK2, SRC, TEK |
2.17979 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.16635 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.16635 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.1074 |
[MF] GO:0032555 |
purine ribonucleotide binding
|
ALK, AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTK2, SRC, TEK |
2.07701 |
[MF] GO:0016740 |
transferase activity
|
ALK, AURKB, AXL, CDK6, CSNK2A1, EGFR, FDPS, FLT3, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTK2, SRC, TEK, TNKS, TNKS2 |
2.0736 |
[MF] GO:0017076 |
purine nucleotide binding
|
ALK, AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTK2, SRC, TEK |
2.04965 |
[MF] GO:0032553 |
ribonucleotide binding
|
ALK, AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTK2, SRC, TEK |
2.04449 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.03856 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.0235 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.0235 |